June 30, 2010 TB Program Thailand MOPH – U.S. CDC Collaboration TB Project Implementation: Impact on NTP?

Slides:



Advertisements
Similar presentations
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Advertisements

Unit 1. Introduction TB Infection Control Training for Managers at the National and Subnational Levels.
PPM-DOTS in Cambodia Working with Private Pharmacies DOTS Expansion WG Meeting Paris 15 th October 2008 Dr. Mao Tan Eang Director National Center for TB.
Improving diagnosis TB laboratory strengthening.
Involving all health care providers in collaborative TB/HIV activities Eva Nathanson PPM subgroup meeting Cairo, Egypt, 3-5 June 2008.
The Global Laboratory Initiative Assisting countries to implement the WHA resolution on MDR-TB Karin Weyer, WHO-STB, GLI secretariat John Ridderhof, CDC,
Dr R Ramachandran 5 th Joint International Monitoring Mission to Review NTP Thailand 5th JMM Thailand.
Ram Deo Chaudhary Programme Manager, BNMT. Outlines VMGO of BNMT Guiding principles of partnership Historical background Current efforts Strengths Area.
Rapporteur: Dr. Massimo Ghidinelli Facilitator: Dr.Elvira Teodora Wi
Accelerating PMDT scale up in Ethiopia
GUIDELINES & TOOLS for HOSPITAL DOTS LINKAGE (HDL)
Introduction Thailand one of 22 countries which contain 80% of the estimated tuberculosis (TB) cases in the world. Thailand ranks 17 th among the 22 high-burden.
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
COUNTRY XEPERIENCE AND RESPONSE TO MDR AND XDR TUBERCULOSIS PRESENTED AT THE WHO TB/HIV PLANNING MEETING, ADDIS ABBABA, 11-12, NOVEMBER 2008 BY MS GUGU.
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
National TB/ Leprosy Programme Manager
Accelerating TB/HIV activities in Zambia Alwyn Mwinga 2007 HIV Implementers Meeting 20 June 2007.
African Business Leaders on Health GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 2010 Technical Assistance.
Unit 9. Human resource development for TB infection control TB Infection Control Training for Managers at National and Subnational Level.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
TB/HIV/AIDS Prevention and Management in the Workplace: Forging new partnerships- by Thinking Ahead Anthony Pramualratana.
Framework and Standards for Effective TB Control Module 3 – March 2010
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
Improving TB-DM Care in the Pacific: Partnerships and Progress R. Brostrom, MD-MSPH Hawaii TB Control Branch Chief Regional TB Field Medical Officer, CDC-DTBE.
Progress and Plans for PPM in the Western Pacific Region Fifth PPM DOTS Subgroup Meeting Cairo, Egypt.
“World TB day and TB in Mongolia”
Unit 10. Monitoring and evaluation
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
1 Oct 2005 WHO/STB/THD World Health Organization 4 th Meeting of Subgroup on laboratory capacity strengthening Paris, France, October Ernesto Jaramillo.
Implementation of Collaborative TB/HIV Activities by ICAP: Success and Challenges Andrea Howard, M.D., M.S. 14 th Core Group Meeting of TB/HIV Working.
Epidemiologic Studies Consortium Research CTCA meeting October 22, 2010 Lisa Pascopella, PhD, MPH California Department of Health Services.
TB/HIV COLLABORATION IN GHANA Dr. Nii Nortey Hanson – Nortey National TB Control Programme Accra.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
1 DEWG meeting October 2009 Human Resource Development for TB Control (HRD-TB) Sub Group within the DEWG of the Stop TB Partnership. Wanda Walton.
Progress and plans for PPM in the WHO Region of the Americas Fifth PPM Subgroup Meeting June, Cairo.
TB Control Measures: From development and endorsement to adoption and implementation Léopold Blanc TBS Stop TB department WHO Christy Garcia University.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Report of the 2nd ad hoc Committee on the TB epidemic Jaap F. Broekmans STOP TB Partner’s Forum NEW DELHI June 2004.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
Maggie Montgomery Water and Health Conference, Chapel Hill Oct 2015 International Network on Household Water Treatment and Safe Storage Regional Workshops.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Intensified TB case finding and infection control in Tanzania – opportunities and challenges Denis Tindyebwa Technical Director EGPAF Tanzania.
Facility supervision by the District Health Teams (DHTs) in Rwanda Track1 Meeting Maputo, Mozambique, August 10 th -12 th Dr. Ruben Sahabo.
Thailand TB Situation Dr. Chawetsan Namwat Director Bureau of Tuberculosis 23 August
11 Laboratory Quality Improvement for clinical HIV/AIDS Services in the Uniformed Forces Mwaibako, J, Shija, L; Haverkamp, G; van den Hombergh; Katebalila,
Measures to Decrease TB Prevalence in the Barents Region Andrey O. Maryandyshev Elena I. Nikishova Dmitry V. Perkhin.
PMDT IN CHINESE TAIPEI ECONOMY Anita Pei-Chun Chan, MD, PhD Medical Officer, TCDC Associated Director, TB Research Center, TCDC Assistant Professor, Institute.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Taipei, June Content  Introduction about Vietnam’s Programmatic Management of Drug resistant Tuberculosis (PMDT) and drug resistant tuberculosis.
Thailand experience in implementing collaborative HIV/TB activities Anupong Chitwarakorn, MD Ministry of Public Health, Thailand TB/HIV Satellite symposium.
Monitoring and Evaluation: A Review of Terms
Charles D. Wells, MD Chief, International Research and Programs Branch
TB/HIV surveillance : Who is going to get the job done?
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
What is best practice and what are the main challenges?
Knowledge gaps in formulating TB Control Policies for Prisons
Key issues in DOTS implementation
Enablers for nationwide expansion of collaborative TB/HIV activities
Objectives of Session Provide an overview of the development of Compendium Explain the organization of the Compendium and how indicators are used Provide.
TB Strategy & Health Systems (TBS) TB Monitoring & Evaluation (TME)
Petchsri Sirinirund Advisor to HIV/AIDS Policy and Programme
5th DEWG meeting Conclusions
South Africa: From ProTest to Nationwide Implementation
The STOP TB Strategy – 2009 VISION: A TB-free world
Current status – (1) Achievements Building strong political commitment
Monitoring and Evaluation: A Review of Terms
Presentation transcript:

June 30, 2010 TB Program Thailand MOPH – U.S. CDC Collaboration TB Project Implementation: Impact on NTP?

Overview SurveillanceResearchTraining Technical Assistance

Active Population-Based Surveillance and Enhanced Control of TB: The Thailand TB Active Surveillance Network (TB-Net)

Partners and project sites Ministry of Public Health Bangkok Metropolitan Administration (BMA) Research Institute of Tuberculosis (Japan) Thailand MOPH – U.S. CDC Collaboration Non- and inter- governmental organizations Funded: USAID, GDD,GAP Chiang Rai Tak Ubon-ratchathani Bangkok Phuket

Difference between Active Surveillance Network and Routine TB Control in Thailand Active, not passive, surveillance of diagnosed cases Data from private, NGO, and non-MOPH government facilities Electronic recording of individual cases, not summary Expanded data collection Continuous data analysis More than microscopy: culture (province), DST (referred) Integration of HIV counseling, testing, treatment

Goal of TB Net Develop models for TB prevention and control by –Measuring incidence of diagnosed TB, HIV co-infection, and MDR-TB –monitoring epidemiologic and clinical features of TB –developing, studying, implementing, and monitoring TB prevention and control strategies in Thailand

Objectives of TB Net Develop model program for measuring incidence, mortality from TB, TB/HIV, and MDR-TB, and to monitor changes over time; Use surveillance data to assess impact of public health interventions, detect outbreaks, allocate resources, guide public health and clinical practice; Build human resources and technical capacity in epidemiology, laboratory, and information technology; Develop platform for operational research on TB and TB/HIV, and to assess the impact of public health interventions.

Activities of TB-Net All persons diagnosed with TB in public and private health care facilities Standard epidemiologic data at beginning and end of treatment Culture, susceptibility testing HIV counseling, testing Monitor HIV care services for TB patients Electronic recording and reporting Treatment Diagnosis HIV TB Private Sector Healthcare Surveillance Drug-resistance Research

Have we met the objectives? Model to assess incidence/mortality Model to assess incidence/mortality Assess interventions, guide practice Assess interventions, guide practice Build epi, lab, IT capacity Build epi, lab, IT capacity Platform for operational research Platform for operational research >10 manuscripts published addressing programmatic and surveillance questions >10 manuscripts published addressing programmatic and surveillance questions Many aspects of TB Net now routine Many aspects of TB Net now routine – TB/HIV initiatives (PITC, ART training) – Access to liquid culture – Electronic data collection

Have we met 2 nd Global Plan to Stop TB, ? DOTS expansion and enhancement Address TB/HIV and MDR-TB Establish Public-private partnerships Enable and promote research Strengthen health-system Empower patients and communities √√√√?√√√√?

Policy Change Impact TUC/TB Contribution National policy adopted to perform HIV counseling and testing on TB patients Built evidence base; tested strategy; financial support for planning workshop in Viet Nam; technical assistance on drafting initial plan National TB recording / reporting system revised to include HIV-related data Built evidence base;; revised national forms based largely on forms developed for Ubon project

Better Public Health Outcomes Impact TUC/TB Contribution Increased case finding in Bangkok, Phuket Provided infrastructure and technical guidance to enhanced public and private collaboration, TB program monitoring Decreased death rate and increased TB success rate among TB/HIV in Ubon, and Chiang Rai Provided infrastructure and technical guidance Increased sputum conversion rate and treatment success rate in Phuket and Bangkok Provided infrastructure and technical guidance Increased proportion of patients receiving HIV counseling and testing in Bangkok, Chiang Rai, Phuket, Tak, and Ubon Provided infrastructure and technical guidance

Enhanced Capacity (1) Impact TUC/TB Contribution More rapid, sensitive diagnostic methods for TB in Bangkok. Chiang Rai, Phuket, Tak, Ubon Provided infrastructure and technical guidance Access to routine drug susceptibility testing for Bangkok, Chiang Rai, Phuket, Tak, Ubon Provided infrastructure and technical guidance Electronic recording and reporting implemented in Bangkok, Chiang Rai, Phuket, Tak, Ubon, Bamrasnaradura Institute Provided infrastructure and technical guidance

Enhanced Capacity (2) Impact TUC/TB Contribution Measuring outcomes of public health interventions by conducting operational research Provided infrastructure and technical guidance; Observational study launched to understand causes of high, early mortality rate in TB/HIV patients Training of public health staff in TB, Laboratory and TB/HIV management Provided infrastructure and technical guidance Enhanced capacity for TB outbreak response Outbreaks investigated at Phuket Vachira Hospital and Wat Tham Krabok with laboratory, IT, epidemiologic, statistical support from TUC

Exporting of Models Impact TUC/TB Contribution Expanded TB/HIV partnerships in Northeastern Thailand Lessons learned in Ubon project applied to other provinces by using resources from GFATM Expanded Public- Private- Partnerships (PPP) in Bangkok Lessons learned in 2 health centers (HC) of Bangkok project applied to 7 HCs then 19 HCs WHO TB/HIV training course for SEARO countries Curriculum development; organization; Hosting of site visits at project sites

Lab Capacity building to TB Active Surveillance Network (1) Improve lab capacity and ability including infrastructure, equipments and reagents Human resource: hiring full time staffs and support staff to present in international conference Provide Technical support for new diagnostic tools implementation (Liquid media culture, Capilia TB and Hain test)

Develop and implement Electronic data recording Support Lab quality control - Collaborate with NTRL for monitoring and supervision and supervision - Participation in External Quality Assurance of College of American Pathologists of College of American Pathologists - Organize training on Standard Operating Procedure of TB culture and Good Procedure of TB culture and Good Laboratory Practices Laboratory Practices Lab Capacity building to TB Active Surveillance Network (2)

Do we have Impact on TB Lab ? Liquid culture Implementation Liquid culture Implementation Implementation of Rapid identification by strip speciation (Capilia TB and SD Bioline) (Capilia TB and SD Bioline) Expansion of Electronic recording Expansion of Electronic recording for lab data for lab data

Lessons Learned Active surveillance increases case finding –Enables comparisons between public and private sector TB treatment outcomes Enhanced laboratory capacity, performance MDR-TB rates ~1-4% consistent with national estimates – no hidden epidemic Increased TB/HIV collaboration for testing, linkages to care Rich database for operational research

Challenges Have engaged private sector to share data for monitoring and evaluation, but need strategy to elevate private sector’s standard of care System developed and integrated into MOPH, but many competing reporting systems proposed in MOPH – need unified national standard for TB How to translate implementation models into routine practice and scale up?

Observational study of HIV-infected TB patients Improving diagnosis of TB in HIV-infected persons Improving diagnosis of TB in HIV-infected persons Public health impact of implementing the GenoType® MTBDRplus assay for diagnosis and management of drug-resistant TB in Thailand Research (1)

Evaluation of a program to enhance TB laboratory services in Thailand: Did providing TB drug-susceptibility results to physicians change clinical practice? Performance comparison of SD Bioline TB AG MTP 64 Rapid with Capilia TB NEO for mycobacterial species identification from broth- based culture at ODPC7, Ubon Ratchathani Research (2)

Training Operational research Counseling –HIV Diagnosis counseling and testing in TB patients Increasing ART use in HIV-infected TB patients TB infection control, collaboration with WHO TB/HIV inter-country, collaborate with WHO Laboratory: SOP, AFB, Culture, DST, EQA

Technical Assistance NTP program Outbreak response Lab capacity building Epidemiological & statistical consultation Manuscript development for TB-Net

Future Directions Continued focus on 3 key areas: research, training, technical assistance Focus on lab capacity building and improving diagnosis in routine care settings Operational research in improving IC, ICF/IPT in HIV Increased focus on MDR TB

Thank you for your attention